It is therefore challenging to ascertain whether reduced osteocalcin levels contribute to elevated osteosarcoma incidence, whether increased osteosarcoma incidence is attributable to p53 rearrangements, or if both factors are involved. This evidence concerns the gene TP53 and osteosarcoma.